In the context of NKG2D-expressing exosomes, the enhanced expression of NKG2D driven by IL24 could improve the ability of NK-Exos to recognize and bind to tumor cells expressing NKG2D ligands (NKG2DLs) (Figure 3H,I). This evidence concerns the gene KLRK1 and neoplasm.